Skip to content

Measuring Erythrocyte Iron Incorporation From Different Dosing Regimens in Anemic Women

Defining Systemic Control of Iron Absorption to Optimize Oral Iron Supplementation Regiemns for Women With Iron Deficiency Anemia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03623997
Enrollment
20
Registered
2018-08-09
Start date
2017-10-10
Completion date
2018-06-30
Last updated
2018-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iron Deficiency Anemia

Brief summary

Iron-deficient anaemic subjects are likely to benefit most from oral iron supplements, but supplementation schedules vary widely in clinical practice, absorption is low and compliance is poor due to mild gastrointestinal side effects. The investigators will compare iron absorption from labeled oral iron doses of 100mg and 200mg administered either on two consecutive days or on alternate days in young anemic women.

Interventions

OTHERIron stable isotope labeled iron(II) sulfate

Administration of oral stable isotope labels using different dosings and different regimens in women with iron deficiency anemia

Sponsors

Swiss Federal Institute of Technology
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Ferritin \<15 µg/L * Hb 8-11.9 g/dl * BMI 18.5-24.9 kg/m2 * Body weight \<70 kg

Exclusion criteria

* Severe anemia (Hb \<8 g/dl) * Elevated CRP \>5.0 mg/L * Chronic disease * Long-term medication, except contraception * Consumption of Mineral and Vitamin supplements within the study period * Therapeutic iron infusion over the past 6 months * Pregnancy or breastfeeding * Smoking

Design outcomes

Primary

MeasureTime frameDescription
Fractional and total iron absorptionabsorption will be measured 14days after the 100mg and 200mg cycleFractional and total iron absorption from different supplementation regimens
Serum hepcidinright before the administration of an iron doseSerum hepcidin after the administration of different doses and using different regimens
Serum EPOright before the administration of an iron doseSerum EPO after the administration of different doses and using different

Secondary

MeasureTime frameDescription
Serum AGPright before the administration of an iron doseDetermination of inflammation status
Serum ferritinright before the administration of an iron doseDetermination of iron status
Total iron binding capacityright before the administration of an iron doseDetermination of iron status
Serum ironright before the administration of an iron doseDetermination of iron status
Serum TfRright before the administration of an iron doseDetermination of iron status
Serum CRPright before the administration of an iron doseDetermination of inflammation status

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026